Glukosalina I

Glukosalina I is an intravenous injection solution that contains the active ingredients sodium chloride and glucose. It is supplied in a sterile liquid form for infusion into the bloodstream. The product is marketed in the European Union and is used as an electrolyte and carbohydrate source in clinical settings. Its composition provides isotonic fluid replacement and energy support during medical procedures.

Glukosalina I is employed in various clinical situations where fluid, electrolyte, and energy supplementation are required. It may be used for: - Intravenous rehydration in patients with fluid loss. - Maintenance of electrolyte balance during surgery. - Providing a source of glucose for patients unable to eat. - Dilution and administration of other intravenous medications. - Support during perioperative fasting periods. - Treatment of mild hypoglycemia under medical supervision.

Side effects of Glukosalina I are generally related to its components and route of administration.

Common: - Mild local irritation at the infusion site. - Transient increase in blood glucose levels. - Slight electrolyte shifts, such as mild hypernatremia. - Headache or dizziness during rapid infusion. - Nausea or mild gastrointestinal discomfort.

Serious: - Severe hyperglycemia in susceptible individuals. - Significant electrolyte imbalance (e.g., hypernatremia, hyperchloremia). - Allergic reaction presenting as rash, itching, or anaphylaxis. - Fluid overload leading to pulmonary edema. - Venous thrombosis at the catheter site.

When using Glukosalina I, healthcare professionals should consider several safety measures. Important precautions include: - Assessing the patient’s baseline electrolyte and glucose status before infusion. - Adjusting infusion rate in patients with cardiac or renal impairment to avoid fluid overload. - Monitoring blood glucose levels in diabetic patients. - Using aseptic technique to prevent infection at the injection site. - Avoiding rapid bolus administration unless clinically indicated. - Observing for signs of allergic reaction during and after infusion. - Documenting the total volume administered to prevent overhydration.

Glukosalina I may interact with other medications or clinical conditions. Interactions to consider are:

Avoid: - Co-administration with hypertonic glucose solutions that could exacerbate hyperglycemia. - Simultaneous use of high-dose sodium-containing drugs that may cause severe hypernatremia. - Intravenous potassium supplements without electrolyte monitoring.

Use with caution: - Concurrent diuretics, which may alter fluid and electrolyte balance. - Insulin therapy, requiring close glucose monitoring. - Medications that affect renal function, such as ACE inhibitors. - Blood thinners, due to potential dilutional effects on coagulation parameters.